Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?
dc.contributor.author | Milionis, H. J. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.date.accessioned | 2015-11-24T18:54:10Z | |
dc.date.available | 2015-11-24T18:54:10Z | |
dc.identifier.issn | 1097-6744 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18653 | |
dc.rights | Default Licence | - |
dc.subject | Anticholesteremic Agents/*administration & dosage | en |
dc.subject | Drug Therapy, Combination | en |
dc.subject | Heptanoic Acids/*administration & dosage | en |
dc.subject | Humans | en |
dc.subject | Hypolipidemic Agents/*administration & dosage | en |
dc.subject | Metabolic Syndrome X/*drug therapy | en |
dc.subject | Niacin/*administration & dosage | en |
dc.subject | Pyrroles/*administration & dosage | en |
dc.subject | Simvastatin/*administration & dosage | en |
dc.title | Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1016/j.ahj.2004.12.017 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/16084140 | - |
heal.identifier.secondary | http://ac.els-cdn.com/S0002870304009172/1-s2.0-S0002870304009172-main.pdf?_tid=f916eac8534eede05ded20182f4551be&acdnat=1333534215_a60f70c47dd16cf9d7e61b18757b4c33 | - |
heal.journalName | Am Heart J | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2005 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: